TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -2 | 3 | 6 | 0 | 22 | -15 | 3 |
| S | %wins | 100 | 50 | 50 | 50 | 50 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/3/15 19:40 | 6/1/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Nussbaum Ran | CA | D | S.m | -16,906 | 55.35 | 33 | -305 | -100 | 0 | I | 32 | -10 | -6 | 0 | 6 | 5 | 0 | 8 | 16 | -2 | 50 | -7 | |||
3/31/15 20:38 | 3/27/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Nussbaum Ran | CA | D | S.m | -11,710 | 60.45 | 33 | -194 | -82 | 44 | I | 114 | 11 | -3 | -8 | -18 | -4 | -3 | -3 | -4 | 2 | -6 | -22 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |